[1]
A. N. Asamoah, “The Cost of Ignoring Pharmacogenomics: A U.S.Health Economic Analysis of Preventable Statin and Antihypertensive Induced Adverse Drug Reactions”, SRMsJMS, vol. 8, no. 01, pp. 55-61, Jun. 2023.